"Your health is finally in your hand"
PhysioCue, Inc. is a four-year-old consumer digital health and therapy device development company located in the heart of Silicon Valley. PhysioCue devices empower people with high blood pressure to live healthier, happier and longer lives.
We have developed an innovative, non-invasive approach to thermo-neuro-stimulation of the nervous system for immediate and sustainable hypertension reduction therapy management that includes our patented BP Bio-sensor (PPG & ECG) technology.
PhysioCue's therapy devices are portable, rechargeable, efficient, safe and user-friendly, and they have none of the side effects associated with anti-hypertension drugs. By providing the right information, tools, and support at the right time, we provide our customers and their caregivers with real-time, personalized insights to make hypertension reduction and BP monitoring manageable.
Jonathan Leong, CEO, is a serial entrepreneur with over 35 years of experience in the management of investment in companies in the healthcare, consumer products, and technology industries.
Mr. Leong has served on 27 boards of public, private, and non-profit companies, and is a partner and investment advisor to several multination funds.
Founder & CTO & COO
Simon Yi, Founder, CTO, is a serial entrepreneur, investor, and executive with a unique combination of product vision, technical depth, and start-up expertise. His passion is to build a quality product and experience from the ground up. Simon was a co-founder of VORA OIL and was the Vice President of Technology and a co-founder at NeuroSky, which focused on the manufacturing and R&D of biosensors. He was a vice president of OpticLayer, a optical telecom system manufacturer.
Hugh Sharkey, Chief Regulatory Officer, is a medical device developer/entrepreneur who has been a principal in several start-up companies including Aerendir Mobile, AEGEA Medical; Cardiokinetix, Oratec Interventions, RITA Medical, VIDAMed, Danforth Biomedical, and EP Technologies. He was the Chair of the Device Investment Committee for the Life Science Angels, 2007 – 2009, and is an inventor on over 140 issued patents and 70 pending applications.
MD, MPH, SMO
Uli Chettipally, MD, MPH, Chief Medical Officer, a speaker, physician, researcher and an innovator. He is the co-founder and Chief Technology Officer of CREST Network, a multi-center, collaborative research network in Kaiser Permanente, covering 21 hospitals in Northern California. He designed, developed and implemented a region-wide clinical decision support platform to deliver real-time guidance to physicians to decrease inappropriate utilization. He holds a faculty position as Assistant Clinical Professor of Medicine at University of California, San Francisco.
PhD, VP of Clinical Trial
Dr. Vora has designed, managed, supervised and completed multiple international clinical trials for Phase 1 through Phase 4 studies with successful outcomes.His expertise also extends to the fields of pharmacovigilance and drug safety, pharmacology, and therapeutic innovation.Dr. Vora obtained his BS Degree from the University of Michigan and his MS and PhD Degrees in Pharmacy from the University of Maryland.
VP of Marketing
James Choi, VP of Business Development, is seasoned professional with 20+ years of international entrepreneurial experiences from start-ups to public corporations, product design to manufacturing, agriculture to cutting edge IT technologies in consumer and industrial products, and distribution to OEM sales and operations. James previously held executive positions with HANA Micron America, AniTrace, and HANA Innosys in US and Brazil.